Brief: Castle Biosciences Announces Preliminary Fourth Quarter And Full-Year 2023 Results
08/01/2024 01:04
Jan 7 (Reuters) - Castle Biosciences Inc CSTL.O :
* CASTLE BIOSCIENCES ANNOUNCES PRELIMINARY FOURTH QUARTER
AND
FULL-YEAR 2023 RESULTS
* CASTLE BIOSCIENCES INC - EXPECT TO DELIVER 2023 TOTAL
REVENUE OF
MORE THAN $210 MILLION, AT LEAST 53% GROWTH OVER 2022
Source text for Eikon: ID:nBw3SwwJWa
Further company coverage: CSTL.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Castle Biosciences
See all newsBrief: Castle Biosciences, - Opens New Laboratory And Office Facility In Scottsdale, Arizona
U.S. RESEARCH ROUNDUP-Abbvie, Amazon, Illumina
Castle Biosciences Inc reports results for the quarter ended June 30 - Earnings Summary
Castle Biosciences beats Q2 revenue estimates, hikes forecast
Brief: Castle Biosciences Q2 Revenue USD 103.546 Million Vs. IBES Estimate USD 86.2 Million